Cardiovascular disease is the leading cause of morbidity and mortality worldwide.
Myocardial fibrosis plays an important role in adverse outcomes such as heart failure and …

Myocardial fibrosis is a major contributor to the development and progression of heart
failure. Significant progress in the understanding of its pathobiology has led to the …

The current era has seen major advances in myocardial imaging. We are now able to
assess cardiac anatomy, function, tissue composition and disease activity across a wide …

Myocardial fibrosis, a common pathophysiological consequence of various cardiovascular
diseases, is characterized by fibroblast activation and excessive deposition of extracellular …

Vulnerability among cardiac patients is multifactorial and may arise from myocardial
interstitial disease (eg, fibrosis or amyloidosis) or other derangements such as valve …

Myocardial fibrosis (MF) is defined as excessive production and deposition of extra-cellular
matrix (ECM) proteins that result in pathologic myocardial remodeling. Three types of MF …

Myocardial fibrosis is recognized as a key pathological process in the development of
cardiac disease and a target for future therapeutics. Despite this recognition, the assessment …

As a result of stress, injury, or aging, cardiac fibrosis is characterized by excessive
deposition of extracellular matrix (ECM) components resulting in pathological remodeling …

Several promising applications of cardiac molecular fibroblast activation protein (FAP)
imaging are emerging. Myocardial fibrosis plays a key role in the complex process of cardiac …

Heart failure is a leading cause of mortality and hospitalization worldwide. Cardiac fibrosis,
resulting from the excessive deposition of collagen fibers, is a common feature across the …